Understanding health disparities in young cancer survivors
Social genomic mechanisms of health disparities among Adolescent and Young Adult (AYA) cancer survivors
This study is looking at how social issues and genetics affect the health of young people who have survived cancer, aiming to understand the challenges they face after treatment so we can help improve their lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10923982 on NIH RePORTER |
What this research studies
This research investigates how social and genomic factors contribute to health disparities among adolescent and young adult (AYA) cancer survivors. It focuses on understanding the unique psychosocial challenges these individuals face after treatment, including the impact of social determinants like socioeconomic status and experiences of discrimination. By studying a cohort of 2000 AYA cancer survivors, the research aims to uncover the biological pathways that link these social factors to health outcomes, ultimately improving the quality of life for this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults aged 12-20 who have recently completed treatment for Hodgkin or non-Hodgkin lymphoma.
Not a fit: Patients who are not within the age range of 12-20 or who have not undergone treatment for the specified cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted interventions that improve health outcomes and quality of life for young cancer survivors.
How similar studies have performed: Previous research has shown that understanding the interplay between social factors and health outcomes can lead to significant improvements in care for cancer survivors, suggesting that this approach has potential for success.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Zebrack, Bradley Jay — University of Michigan at Ann Arbor
- Study coordinator: Zebrack, Bradley Jay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.